Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113

被引：0

作者：

Tatsuya Okuno ^{[1
]}

Chigusa Morizane ^{[2
]}

Junki Mizusawa ^{[3
]}

Hiroaki Yanagimoto ^{[4
]}

Satoshi Kobayashi ^{[5
]}

Hiroshi Imaoka ^{[6
]}

Takeshi Terashima ^{[7
]}

Hisato Kawakami ^{[1
]}

Yusuke Sano ^{[3
]}

Takuji Okusaka ^{[2
]}

Masafumi Ikeda ^{[6
]}

Masato Ozaka ^{[8
]}

Haruo Miwa ^{[9
]}

Akiko Todaka ^{[10
]}

Satoshi Shimizu ^{[11
]}

Nobumasa Mizuno ^{[12
]}

Mitsugu Sekimoto ^{[13
]}

Keiji Sano ^{[14
]}

Kazutoshi Tobimatsu ^{[15
]}

Akio Katanuma ^{[16
]}

Kunihito Gotoh ^{[17
]}

Hironori Yamaguchi ^{[18
]}

Hiroshi Ishii ^{[19
]}

Junji Furuse ^{[5
]}

Makoto Ueno ^{[5
]}

机构：

[1] Kindai University,Department of Medical Oncology, Faculty of Medicine

[2] Osakasayama City,Department of Hepatobiliary and Pancreatic Oncology

[3] National Cancer Center Hospital,JCOG Data Center/Operations Office

[4] National Cancer Center Hospital,Department of Surgery, Division of Hepato

[5] Kobe University Graduate School of Medicine,Biliary

[6] Kanagawa Cancer Center,Pancreatic Surgery

[7] National Cancer Center Hospital East,Department of Gastroenterology

[8] Kanazawa University Hospital,Department of Hepatobiliary and Pancreatic Oncology

[9] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterology

[10] Yokohama City University Medical Center,Hepato

[11] Shizuoka Cancer Center,Biliary

[12] Saitama Cancer Center,Pancreatic Medicine Department

[13] Aichi Cancer Center Hospital,Gastroenterological Center

[14] Kansai Medical University Hospital,Division of Gastrointestinal Oncology

[15] Teikyo University School of Medicine,Department of Gastroenterology

[16] Kobe University Graduate School of Medicine,Department of Gastroenterology

[17] Teine Keijinkai Hospital,Department of Surgery

[18] NHO Osaka National Hospital,Department of Surgery

[19] Jichi Medical University,Division of Gastroenterology, Department of Internal Medicine

[20] Chiba Cancer Center,Center for Gastroenterology

来源：

International Journal of Clinical Oncology | 2025年 / 30卷 / 1期

关键词：

Biliary tract cancers; Chemotherapy; Major hepatectomy;

D O I：

10.1007/s10147-024-02642-9

中图分类号：

学科分类号：

摘要：

引用

页码：83 / 91

页数：8

共 50 条

[21] Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202
Kobayashi, Shogo
Nakachi, Kohei
Ikeda, Masafumi
Konishi, Masaru
Ogawa, Gakuto
Sugiura, Teiichi
Yanagimoto, Hiroaki
Morinaga, Soichiro
Wada, Hiroshi
Shimada, Kazuaki
Takahashi, Yu
Nakagohri, Toshio
Kamata, Ken
Shimizu, Yasuhiro
Ajiki, Tetsuo
Hirano, Satoshi
Gotohda, Naoto
Ueno, Makoto
Okusaka, Takuji
Furuse, Junji
EJSO, 2024, 50 (01):
[22] Feasibility of adjuvant S-1 chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202
Kobayashi, Shogo
Nakachi, Kohei
Ikeda, Masafumi
Konishi, Masaru
Ogawa, Gakuto
Uesaka, Katsuhiko
Yanagimoto, Hiroaki
Morinaga, Soichiro
Wada, Hiroshi
Shimada, Kazuaki
Takahashi, Yu
Nakagohri, Toshio
Gotoh, Kunihito
Kamata, Ken
Shimizu, Yasuhiro
Ajiki, Tetsuo
Kawamoto, Yasuyuki
Ueno, Makoto
Okusaka, Takuji
Furuse, Junji
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[23] EVALUATION OF CHEMOTHERAPY WITH CISPLATIN-GEMCITABINE AFTER FAILURE OF GEMCITABINE MONOTHERAPY FOR UNRESECTABLE OR RECURRENT BILIARY TRACT CANCER
Kameda, R.
Ando, T.
Kobayashi, S.
Ueno, M.
Ohkawa, S.
ANNALS OF ONCOLOGY, 2012, 23 : 162 - 162
[24] Efficacy and safety of durvalumab and gemcitabine-based chemotherapy combined with or without lenvatinib in advanced biliary tract cancer.
Ding, Qi
Sun, Yubei
Wang, Gang
Song, Ruipeng
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
[25] Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)
Mizusawa, Junki
Morizane, Chigusa
Okusaka, Takuji
Katayama, Hiroshi
Ishii, Hiroshi
Fukuda, Haruhiko
Furuse, Junji
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (04) : 385 - 388
[26] Multicenter phase II trial of axitinib monotherapy for advanced biliary tract cancer refractory to gemcitabine-based chemotherapy
Okaro, N.
Ueno, M.
Morizane, C.
Yamanaka, T.
Ojima, H.
Ozaka, M.
Sasaki, M.
Takahara, N.
Kobayashi, S.
Morimoto, M.
Hosoi, H.
Nakai, Y.
Ikeda, M.
Maeno, S.
Nagashima, F.
Okusaka, T.
Furuse, J.
ANNALS OF ONCOLOGY, 2019, 30 : 283 - 283
[27] Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113).
Morizane, Chigusa
Okusaka, Takuji
Mizusawa, Junki
Katayama, Hiroshi
Ueno, Makoto
Ikeda, Masafumi
Ishii, Hiroshi
Azuma, Takeshi
Iguchi, Haruo
Nakamori, Shoji
Mizuno, Nobumasa
Sata, Naohiro
Sugimori, Kazuya
Yamaguchi, Konsei
Mine, Tetsuya
Sano, Keiji
Maguchi, Hiroyuki
Shimizu, Kyoko
Furuse, Junji
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[28] Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
Kim, Mi-Jung
Oh, Do-Youn
Lee, Se-Hoon
Kim, Dong-Wan
Im, Seock-Ah
Kim, Tae-You
Heo, Dae Seog
Bang, Yung-Jue
BMC CANCER, 2008, 8 (1)
[29] Evaluation of chemotherapy with cisplatin plus gemcitabine after failure of gemcitabine alone for unresectable or recurrent biliary tract cancer.
Kameda, Ryo
Ando, Tomoko
Kobayashi, Satoshi
Ueno, Makoto
Ohkawa, Shinichi
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
[30] TOURMALINE: A phase 3b study of durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer
Vogel, Arndt
He, Aiwu Ruth
Oh, Do-Youn
Macarulla, Teresa
Dane, Aaron
Nguyen, Binh
Wetherill, Graham
Baur, Boris
Ikeda, Masafumi
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

← 1 2 3 4 5 →